Rapid Growth Projected in AI in Life Science Analytics Market: Market size set to reach $5.34 billion by 2029, driven by technological advancements and increased AI adoption

 

According to recent data, the AI in life science analytics market has experienced significant growth and is set to continue this upward trend. The market, valued at $2.27 billion in 2024, is anticipated to reach $2.65 billion in 2025, marking a compound annual growth rate (CAGR) of 16.7%. This expansion in the historic period can be credited to several factors including research and development funding, regulatory changes, challenges in drug discovery, digitization in healthcare, and a shift toward patient-centric care.

The forecast for the upcoming years is equally promising. Projections suggest that the market will surge to $5.34 billion by 2029 at an impressive CAGR of 19.1%. This accelerated growth can be attributed to emerging trends such as drug repurposing opportunities, real-world evidence adoption, advancements in genomics, value-based care models, and telemedicine expansion.

Get Your Free Sample of The Global AI In Life Science Analytics Market Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9850&type=smp

What Are the Main Drivers of Growth in the AI in Life Science Analytics Market?
The continued adoption and integration of artificial intelligence (AI) technology is expected to spur the growth of the AI in life science analytics market. Artificial intelligence, which involves large datasets and computer science to facilitate problem-solving, is increasingly being used for a range of purposes in life science analytics, including drug discovery, clinical trials, medical diagnoses, patient monitoring, and personalized medicine. For instance, in 2022, according to the International Business Machines Corporation, roughly 35% of companies worldwide are already leveraging AI, and 42% are planning to incorporate AI into their processes and applications.

What Are the Major Segments in the AI in Life Science Analytics Market?
The key segments in this market include -
1) By Component: Software, Hardware, Services
2) By Deployment: On-Premise, Cloud
3) By Application: Research And Development, Sales And marketing Support, Supply Chain Analytics, Other Applications
4) By End-User: Medical Devices, Pharmaceutical, Biotechnology, Other End Users

You can order your report for swift delivery here:
https://www.thebusinessresearchcompany.com/report/ai-in-life-science-analytics-global-market-report

Who Are the Major Players in the AI in Life Science Analytics Market?
The AI in life science analytics market is dominated by several major players, including Indegene Limited, International Business Machines Corporation, IQVIA Holdings Inc., Lexalytics Inc., Databricks Inc., SAS Institute Inc., Sisense Inc., Sorcero Atomwise Inc., Microsoft Corporation, NVIDIA Corporation, Oracle Corporation, NuMedii Inc., Enlitic Inc., Apixio Inc., AiCure LLC, Google LLC, Amazon Web Services Inc., Accenture, Cognitivescale, CloudMinds, Ayasdi, BioSymetrics, Cloud Pharmaceuticals, Cyrcadia Health, Freenome, GNS Healthcare, Insilico Medicine, MedWhat, PathAI, Recursion Pharmaceuticals, Sophia Genetics, Veracyte Inc.

What Are the Emerging Trends in the AI in Life Science Analytics Market?
Technological advancements are significantly influencing the AI in life science analytics market. For example, in October 2023, Belgium-based biotechnology company BioLizard introduced the AI-powered BioVerse platform, designed to support data-driven R&D for the global life sciences community. With applications like Bio|Reflect for comprehensive literature overviews, Pro|Biome for microbiome analysis, and Bio|Mx for integrating and analyzing multi-omics datasets, the platform aligns with BioLizard's commitment to providing AI-driven solutions for the life sciences industry.

Which Region Is the Fastest Growing in the AI in Life Science Analytics Market?
In 2024, North America was the largest region in terms of market size. However, Asia-Pacific is predicted to be the fastest-growing region in the AI in life science analytics market during the forecast period.

What Does The AI In Life Science Analytics Market Report 2025 Offer?
Artificial intelligence in life sciences analytics involves technology used for data analysis, transforming unstructured data into actionable insights and information. It plays crucial roles in conducting clinical trials, enabling new drug discoveries, and ensuring precise disease diagnoses. The AI In Life Science Analytics Market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.

Purchase the exclusive report here to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9850

About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Comments

Post a Comment

Popular posts from this blog

Global Antiepileptic Drugs Market Forecast Highlights Growth Outlook And Key Trends Over 2026–2030

Image
  The antiepileptic drugs market size has grown strongly in recent years. It will grow from $17.83 billion in 2025 to $18.74 billion in 2026 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to epilepsy prevalence growth, first-generation drug reliance, hospital neurology expansion, seizure disorder awareness, generic drug penetration. The antiepileptic drugs market size is expected to see strong growth in the next few years. It will grow to $22.87 billion in 2030 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to treatment-resistant epilepsy management, novel AED approvals, personalized neurology care, pediatric epilepsy diagnosis, long-acting formulations. Major trends in the forecast period include shift toward third-generation AEDs, growing use of combination therapy, expansion of pediatric epilepsy management, increased adoption of long-term seizure control, growth of gene...
Read more

Global Haptic Virtual Reality (VR) Fitness Suit Market Analysis Highlights Emerging Opportunities And Revenue Forecasts Through 2030

Image
  The haptic virtual reality (vr) fitness suit market size has grown exponentially in recent years. It will grow from $1.6 billion in 2025 to $2.05 billion in 2026 at a compound annual growth rate (CAGR) of 27.7%. The growth in the historic period can be attributed to rising popularity of virtual fitness applications, increasing consumer interest in immersive workouts, growth of wearable fitness technologies, expansion of home-based fitness solutions, improvements in haptic hardware capabilities. The haptic virtual reality (vr) fitness suit market size is expected to see exponential growth in the next few years. It will grow to $5.4 billion in 2030 at a compound annual growth rate (CAGR) of 27.4%. The growth in the forecast period can be attributed to increasing adoption of ai-driven fitness personalization, rising demand for remote and virtual training solutions, expansion of rehabilitation and therapeutic vr applications, growing integration of biometric feedback systems, advan...
Read more

2025 Strategic Guide to the Drugs For Benign Prostatic hypertrophy Market – Forecasts and Business Use Cases

Image
  The drugs for benign prostatic hypertrophy market size has grown strongly in recent years. It will grow from $4.28 billion in 2024 to $4.58 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to aging population, increased awareness, advancements in drug therapies, healthcare access. The drugs for benign prostatic hypertrophy market size is expected to see strong growth in the next few years. It will grow to $5.58 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to emerging markets, new drug developments, increasing awareness and education, regulatory approvals. Major trends in the forecast period include minimally invasive treatments, personalized medicine, combination therapies, patient-centered care, telemedicine and digital health, research and development. #Download Your Free Sample PDF:# https://www.thebusinessresearchcompany.com/sample.a...
Read more